A detailed history of United Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, United Bank holds 3,635 shares of LLY stock, worth $2.74 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares
3,635
Previous 3,665 0.82%
Holding current value
$2.74 Million
Previous $3.32 Million 2.95%
% of portfolio
1.49%
Previous 1.67%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$772.14 - $960.02 $23,164 - $28,800
-30 Reduced 0.82%
3,635 $3.22 Million
Q2 2024

Jul 23, 2024

SELL
$724.87 - $909.04 $16,672 - $20,907
-23 Reduced 0.62%
3,665 $3.32 Million
Q1 2024

May 10, 2024

SELL
$592.2 - $792.28 $71,656 - $95,865
-121 Reduced 3.18%
3,688 $2.87 Million
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $24,683 - $29,099
-47 Reduced 1.22%
3,809 $2.22 Million
Q3 2023

Oct 27, 2023

SELL
$434.7 - $599.3 $26,082 - $35,958
-60 Reduced 1.53%
3,856 $2.07 Million
Q2 2023

Aug 07, 2023

SELL
$350.74 - $468.98 $55,767 - $74,567
-159 Reduced 3.9%
3,916 $1.84 Million
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $357,224 - $419,543
-1,150 Reduced 22.01%
4,075 $1.4 Million
Q4 2022

Feb 10, 2023

SELL
$321.55 - $374.67 $162,382 - $189,208
-505 Reduced 8.81%
5,225 $1.91 Million
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $134,601 - $153,392
-454 Reduced 7.34%
5,730 $1.85 Million
Q2 2022

Aug 05, 2022

SELL
$278.73 - $327.27 $447,919 - $525,922
-1,607 Reduced 20.63%
6,184 $2.01 Million
Q1 2022

May 09, 2022

SELL
$234.69 - $291.66 $51,162 - $63,581
-218 Reduced 2.72%
7,791 $2.23 Million
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $194,944 - $241,927
-867 Reduced 9.77%
8,009 $2.21 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $13,074 - $16,089
59 Added 0.67%
8,876 $2.05 Million
Q2 2021

Jul 26, 2021

SELL
$180.55 - $233.54 $57,595 - $74,499
-319 Reduced 3.49%
8,817 $2.02 Million
Q1 2021

May 12, 2021

SELL
$164.32 - $212.72 $38,122 - $49,351
-232 Reduced 2.48%
9,136 $1.71 Million
Q4 2020

Feb 11, 2021

BUY
$130.46 - $172.63 $86,886 - $114,971
666 Added 7.65%
9,368 $1.58 Million
Q3 2020

Nov 10, 2020

BUY
$146.22 - $169.13 $146,073 - $168,960
999 Added 12.97%
8,702 $1.29 Million
Q2 2020

Aug 05, 2020

BUY
$136.42 - $164.18 $265,746 - $319,822
1,948 Added 33.85%
7,703 $1.27 Million
Q1 2020

May 08, 2020

SELL
$119.05 - $147.35 $143,336 - $177,409
-1,204 Reduced 17.3%
5,755 $798,000
Q4 2019

Feb 03, 2020

BUY
$106.92 - $132.43 $276,815 - $342,861
2,589 Added 59.24%
6,959 $915,000
Q3 2019

Nov 08, 2019

BUY
$106.79 - $116.16 $466,672 - $507,619
4,370 New
4,370 $489,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track United Bank Portfolio

Follow United Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Bank, based on Form 13F filings with the SEC.

News

Stay updated on United Bank with notifications on news.